| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |